267 related articles for article (PubMed ID: 31159258)
1. Epidemiological Trends and Resistance Associated with
Gajdács M; Urbán E
Diseases; 2019 May; 7(2):. PubMed ID: 31159258
[No Abstract] [Full Text] [Related]
2. Prevalence and Antibiotic Resistance of
Gajdács M; Urbán E
Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of trimethoprim/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt.
Elsheredy A; Elsheikh A; Ghazal A; Shawky S
Acta Microbiol Immunol Hung; 2021 Sep; ():. PubMed ID: 34546967
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-Sulfamethoxazole Versus Levofloxacin for
Sarzynski SH; Warner S; Sun J; Matsouaka R; Dekker JP; Babiker A; Li W; Lai YL; Danner RL; Fowler VG; Kadri SS
Open Forum Infect Dis; 2022 Feb; 9(2):ofab644. PubMed ID: 35097154
[TBL] [Abstract][Full Text] [Related]
6. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
Wu RX; Yu CM; Hsu ST; Wang CH
J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
[TBL] [Abstract][Full Text] [Related]
7. Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
Demirbuğa A; Akgün Karapınar DB; Yaşa B; Çoban A; Öngen B; Dede E; Mete Atasever N; Somer A; Hançerli Törün S
Pediatr Neonatol; 2024 Mar; 65(2):183-187. PubMed ID: 37919104
[TBL] [Abstract][Full Text] [Related]
8. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
9.
Hamdi AM; Fida M; Abu Saleh OM; Beam E
Open Forum Infect Dis; 2020 Jan; 7(1):ofaa008. PubMed ID: 32016126
[TBL] [Abstract][Full Text] [Related]
10. The Activities of Antimicrobials Against
Boonmee P; Nasomsong W; Lorchirachoonkul N; Pungcharoenkijkul S; Juntanawiwat P; Chaemchaeng S; Santimaleeworagun W
Infect Drug Resist; 2023; 16():5173-5184. PubMed ID: 37581163
[TBL] [Abstract][Full Text] [Related]
11. A review of 11 years of Stenotrophomonas maltophilia blood isolates at a tertiary care institute in Canada.
Naidu P; Smith S
Can J Infect Dis Med Microbiol; 2012; 23(4):165-9. PubMed ID: 24294268
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of acquired resistance genes in Stenotrophomonas maltophilia].
Song JH; Sung JY; Kwon KC; Park JW; Cho HH; Shin SY; Ko YH; Kim JM; Shin KS; Koo SH
Korean J Lab Med; 2010 Jun; 30(3):295-300. PubMed ID: 20603591
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study.
Almangour TA; Alkherb Z; Alruwaite S; Alsahli R; Alali H; Almohaizeie A; Almuhisen S; Alowais SA; Saleh KB; Fetyani L; Alnashmi F; Alghofaily A; Abouobaid NI; Binkhamis KM; Tawfik EA; Alsowaida YS
J Glob Antimicrob Resist; 2024 May; 38():42-48. PubMed ID: 38821443
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
15. Trends in
Appaneal HJ; Lopes VV; LaPlante KL; Caffrey AR
J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36306237
[No Abstract] [Full Text] [Related]
16. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study.
Nair AP; Sasi S; Al Maslamani M; Al-Khal A; Chacko K; Deshmukh A; Abukhattab M
Cureus; 2022 Mar; 14(3):e23263. PubMed ID: 35449666
[TBL] [Abstract][Full Text] [Related]
18. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis.
Dadashi M; Hajikhani B; Nazarinejad N; Noorisepehr N; Yazdani S; Hashemi A; Hashemizadeh Z; Goudarzi M; Fatemeh S
J Glob Antimicrob Resist; 2023 Sep; 34():253-267. PubMed ID: 36906172
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
20. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]